| Old Articles: <Older 3081-3090 Newer> |
|---|
 |
Chemistry World
August 3, 2012
Andrew Turley |
Pfizer secures Sandwich buyer Pfizer has found a buyer for its R&D site in Sandwich, UK: the site -- now called Discovery Park -- has been bought by a private consortium, according to Kent County Council.   |
CFO
August 1, 2012
Andrew Sawers |
Euro Slide Sparks M&A Interest The weakening currency makes European assets more attractive. |
Chemistry World
July 11, 2012 |
Europe-Wide Single Patent Stalls Again A single European patent is on the wish list of small innovative businesses. |
Chemistry World
June 27, 2012
Laura Howes |
Clariant to sell businesses Swiss speciality chemicals company Clariant has released its strategic targets up until 2015. |
Pharmaceutical Executive
June 1, 2012 |
Europe Responds to Medical Device 'Crisis' A recent medical device controversy in France has pushed European health ministers to agree on a crisis management program for the troubled sector. |
Pharmaceutical Executive
May 1, 2012 |
Value-Based Pricing: Too High a Price for UK Pharma? Changes to the system in the UK could finally put some real metrics behind the elusive concept of value but with payers clearly in the driver's seat, who needs clarity? |
Chemistry World
May 2012 |
Biotech's bravura performer Bibiana Campos Seijo talks to scientist, philanthropist and serial entrepreneur Chris Evans, who is credited with having helped create the UK biotechnology industry. |
CFO
April 15, 2012
Randy Myers |
Like It or Not, You're in the Euro Zone CFOs have to prepare for almost anything in Europe. The good news: it's not all bad news. |
CFO
April 15, 2012
Vincent Ryan |
Europe: Good Days, Bad Days Investment-grade debt issuers take advantage of optimism over a second Greek bailout. |
Pharmaceutical Executive
April 1, 2012
Ben Comer |
Divided Kingdom What does a Scottish vote for independence mean for Big Pharma investment and healthcare funding and delivery in the UK? |
| <Older 3081-3090 Newer> Return to current articles. |
